Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 8, 2009, Pages 1445-1450

  Lee, Hyunseung ^a   Ryu, Soo Hyung ^a   Hong, Soon Sun ^c   Seo, Dong Dae ^b   Min, Hyun Joo ^c   Jang, Myoung Kuk ^d   Kwon, Ho Jeong ^e   Yu, Ensil ^c   Chung, Young Hwa ^c   Kim, Kyu Won ^a  

^a Seoul National University   (South Korea)

^b Inha University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Hallym University Medical Center   (South Korea)

^e Yonsei University   (South Korea)

Author keywords

Hepatocellular carcinoma; Metastasis associated protein 2; Tissue microarray

Indexed keywords

METASTASIS ASSOCIATED PROTEIN 2; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SIZE; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

EID: 69049084616     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05965.x     Document Type: Article

References (27)

1. Idilman R, De Maria N, Colantoni A, Van Thiel DH. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J. Viral Hepat. 1998 5 : 285 299.
2. Sugimachi K, Tanaka S, Terashi T, Taguchi K, Rikimaru T, Sugimachi K. The mechanisms of angiogenesis in hepatocellular carcinoma: angiogenic switch during tumor progression. Surgery 2002 131 (1 Suppl) S135 41.
3. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002 2 : 563 572.
4. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003 3 : 453 458.
5. Bowen NJ, Fujita N, Kajita M, Wade PA. Mi-2/NuRD: multiple complexes for many purposes. Biochim. Biophys. Acta 2004 1677 : 52 7.
6. Kumar R, Wang RA, Bagheri-Yarmand R. Emerging roles of MTA family members in human cancers. Semin Oncol 2003 30 (5 Suppl 16) 30 7.
7. Toh Y, Kuninaka S, Endo K et al. Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. J. Exp. Clin. Cancer Res. 2000 19 : 105 111.
8. Hamatsu T, Rikimaru T, Yamashita Y et al. The role of MTA1 gene expression in human hepatocellular carcinoma. Oncol. Rep. 2003 10 : 599 604.
9. Moon WS, Chang K, Tarnawski AS. Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: relationship to vascular invasion and estrogen receptor-alpha. Hum. Pathol. 2004 35 : 424 429.
10. Hofer MD, Kuefer R, Varambally S et al. The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res. 2004 64 : 825 829.
11. Iguchi H, Imura G, Toh Y, Ogata Y. Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer. Int. J. Oncol. 2000 16 : 1211 1214.
12. Jang KS, Paik SS, Chung H, Oh YH, Kong G. MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Sci. 2006 97 : 374 379.
13. Kim MJ, Hong SM, Jang SJ et al. Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma. Hum. Pathol. 2006 37 : 809 815.
14. Zhang H, Stephens LC, Kumar R. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clin. Cancer Res. 2006 12 : 1479 1486.
15. Martin MD, Hilsenbeck SG, Mohsin SK et al. Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast. Cancer Res. Treat. 2006 95 : 7 12.
16. Yi C, Li X, Xu W, Chen A. Relationship between the expression of MTA-1 gene and the metastasis and invasion in human osteosarcoma. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2005 25 : 445 447.
17. Hofer MD, Menke A, Genze F, Gierschik P, Giehl K. Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. Br. J. Cancer 2004 90 : 455 462.
18. Xia L, Zhang Y. Sp1 and ETS family transcription factors regulate the mouse Mta2 gene expression. Gene 2001 268 : 77 85.
19. Hackel CG, Krueger S, Grote HJ et al. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma. Cancer 2000 89 : 995 1003.
20. Jahkola T, Toivonen T, Virtanen I et al. Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br. J. Cancer 1998 78 : 1507 1513.
21. Cai J, Jiang WG, Mansel RE. Inhibition of the expression of VE-cadherin/catenin complex by gamma linolenic acid in human vascular endothelial cells, and its impact on angiogenesis. Biochem. Biophys. Res. Commun. 1999 258 : 113 118.
22. Yao YL, Yang WM. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J. Biol. Chem. 2003 278 : 42560 42568.
23. Cui Y, Niu A, Pestell R et al. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 2006 20 : 2020 2035.
24. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 1999 13 : 1924 1935.
25. Ji Y, Zhang P, Lu Y, Ma D. Expression of MTA2 gene in ovarian epithelial cancer and its clinical implication. J. Huazhong Univ. Sci. Technol. Med. Sci. 2006 26 : 359 362.
26. Luo J, Su F, Chen D, Shiloh A, Gu W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 2000 408 : 377 381.
27. Gu W, Luo J, Brooks CL, Nikolaev AY, Li M. Dynamics of the p53 acetylation pathway. Novartis Found Symp 2004 259 : 197 205 discussion 05-7, 23-5.